A similar sample was seen with tirzepatide within the SURMOUNT-four trial — contributors who switched from tirzepatide to placebo regained a considerable part of their pounds about 36 months.This follows Novo Nordisk's playbook (Ozempic for diabetes vs Wegovy for obesity — both semaglutide). It is likely that Lilly will give retatrutide at … Read More